SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-275608
Filing Date
2024-12-11
Accepted
2024-12-11 16:30:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d904837dsc13g.htm SC 13G 51895
  Complete submission text file 0001193125-24-275608.txt   53434
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Subject) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91849 | Film No.: 241541928
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Opportunities IV, L.P. (Filed by) CIK: 0002015553 (see all company filings)

IRS No.: 933199560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G